Cargando…
419. Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
BACKGROUND: Accurate, rapid, inexpensive biomarkers are needed to differentiate COVID-19 from bacterial pneumonia, allowing effective treatment and antibiotic stewardship. We hypothesized that the ratio of ferritin to procalcitonin (F/P) reflects greater viral activity and host response with COVID-1...
Autores principales: | Jankousky, Katherine C, Hyson, Peter, Huang, Jin, Chastain, Daniel B, Franco-Paredes, Carlos, Erlandson, Kristine M, Henao-Martinez, Andres, Shapiro, Leland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776875/ http://dx.doi.org/10.1093/ofid/ofaa439.613 |
Ejemplares similares
-
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
por: Gharamti, Amal A., et al.
Publicado: (2020) -
Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study
por: Gharamti, Amal A, et al.
Publicado: (2021) -
Preventing SARS-CoV-2 infection by blocking a tissue serine protease
por: Jankousky, Katherine C., et al.
Publicado: (2020) -
Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
por: Gharamti, Amal A., et al.
Publicado: (2021) -
Use of Procalcitonin to Guide Discontinuation of Antimicrobial Therapy in Patients with Persistent Intra-Abdominal Collections: A Case Series
por: Motoa, Gabriel, et al.
Publicado: (2020)